Besides, miR-7 overexpression associates with a better response in BC patients treated with PTX and carboplatin (CAR) chemotherapy due to negatively regulation of BCL-2 and multidrug resistance-associated protein 1 (MRP1) gene [76]. This evidence concerns the gene MDM4 and breast cancer.